How have you implemented digital data into your evaluations of Parkinson's patients?

e.g. smart watch or wearables. Has it impacted your decisions to change treatment beyond what you would ascertain from clinical data e.g. part 3 of UPDRS? In light of publication by Aubourg et al in BMJ Neurol Open 2026 Jul